Brought to you by 
Abivax gets three vaccines from Finlay Institute
14 Nov 2014
Executive Summary
French antivirals developer Abivax received rights from the Finlay Institute to distribute three vaccines--vax-TyVi for typhoid, VA-MENGOC-BC for groups B & C meningococcus, and vax-SPIRAL for leptospirosis--in certain Asian and Latin American countries.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abivax gets three vaccines from Finlay Institute
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice